Nuclera, the biotechnology company accelerating protein expression and purification workflows through its benchtop protein system, today announced it has completed a USD $75 million financing round (circa £57 million).
Nuclera closes $75 million USD financing
- Post author:
- Post published:October 16, 2024
- Post category:uncategorized